Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02339532
What this trial is testing

Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status

Who this might be right for
Breast Cancer
UNICANCER 86
Not applicableLooking for participantsNCT05057598
What this trial is testing

DianaWeb: Before and After Study Online Based Participatory Research on Breast Cancer Women

Who this might be right for
Breast Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 50,000
Testing effectiveness (Phase 2)UnknownNCT03337087
What this trial is testing

Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer

Who this might be right for
Metastatic Biliary Tract CarcinomaMetastatic Colorectal CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+6 more
Academic and Community Cancer Research United 18
Large-scale testing (Phase 3)UnknownNCT00541021
What this trial is testing

Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Institut Paoli-Calmettes 104
Testing effectiveness (Phase 2)Ended earlyNCT00903006
What this trial is testing

Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 11
Not applicableUnknownNCT03333226
What this trial is testing

Axillary Reverse Mapping (ARM) in Breast Cancer Surgery to Prevent Lymphedema. (ARMtrial)

Who this might be right for
Breast Cancer Lymphedema
University Hospital of Ferrara 300
Large-scale testing (Phase 3)Study completedNCT00519285
What this trial is testing

Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer

Who this might be right for
Prostatic NeoplasmsNeoplasm Metastasis
Sanofi 1,224
Not applicableStudy completedNCT04796935
What this trial is testing

Test Performance of Needle Placements for Neuraxial Procedures Using Tactile Imaging vs Control

Who this might be right for
Central Nervous System InfectionsPseudotumor CerebriNeurological Disorder+4 more
IntuiTap Medical, Inc 95
Testing effectiveness (Phase 2)Active Not RecruitingNCT04920708
What this trial is testing

Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression

Who this might be right for
Metastatic Breast CancerER+ Breast CancerAdvanced Breast Cancer
Royal Marsden NHS Foundation Trust 57
Early research (Phase 1)UnknownNCT03310008
What this trial is testing

Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases

Who this might be right for
Colon Cancer Liver Metastasis
Celyad Oncology SA 36
Early research (Phase 1)Ended earlyNCT02478125
What this trial is testing

Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3
Early research (Phase 1)Looking for participantsNCT07203391
What this trial is testing

Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis

Who this might be right for
Uveal Melanoma, Metastatic
St Vincent's Hospital, Sydney 8
Very early researchLooking for participantsNCT04005690
What this trial is testing

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+5 more
OHSU Knight Cancer Institute 90
Large-scale testing (Phase 3)Study completedNCT00008060
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Medical Research Council
Not applicableUnknownNCT00912080
What this trial is testing

Utilization of Genomic Signature as Decision-making for Adjuvant Treatment of Breast Cancer

Who this might be right for
Breast Cancer
Institut Paoli-Calmettes 375
Testing effectiveness (Phase 2)Study completedNCT04632459
What this trial is testing

Pembrolizumab Plus Ramucirumab in Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Samsung Medical Center 26
Testing effectiveness (Phase 2)Study completedNCT04758780
What this trial is testing

Imaging Performance Assessment of 89Zi-girentuximab (89Zr-TLX250) PET in Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Institut Cancerologie de l'Ouest 12
Testing effectiveness (Phase 2)Looking for participantsNCT06125080
What this trial is testing

The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical Study

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Huihua Xiong 78
Not applicableUnknownNCT02848196
What this trial is testing

An Image-guided SBRT for Adrenal Gland Metastasis in Oligometastatic Patients

Who this might be right for
Adrenal Gland Metastases
Istituto Clinico Humanitas 40
Testing effectiveness (Phase 2)UnknownNCT03693326
What this trial is testing

PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnormalities

Who this might be right for
CancerLung Cancer MetastaticImmunotherapy
Asan Medical Center 70
Next Page